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Abstract: Overweight and obesity have been steadily increasing in recent years and currently
represent a serious threat to public health. Few human studies have investigated the relationship
between polyphenol intake and body weight. Our aim was to assess the relationship between urinary
polyphenol levels and body weight. A cross-sectional study was performed with 573 participants
from the PREDIMED (Prevención con Dieta Mediterránea) trial (ISRCTN35739639). Total polyphenol
levels were measured by a reliable biomarker, total urinary polyphenol excretion (TPE), determined
by the Folin-Ciocalteu method in urine samples. Participants were categorized into five groups
according to their TPE at the fifth year. Multiple linear regression models were used to assess the
relationships between TPE and obesity parameters; body weight (BW), body mass index (BMI),
waist circumference (WC), and waist-to-height ratio (WHtR). After a five years follow up, significant
inverse correlations were observed between TPE at the 5th year and BW (β = −1.004; 95% CI: −1.634
to −0.375, p = 0.002), BMI (β = −0.320; 95% CI: −0.541 to −0.098, p = 0.005), WC (β = −0.742; 95% CI:
−1.326 to −0.158, p = 0.013), and WHtR (β = −0.408; 95% CI: −0.788 to −0.028, p = 0.036) after
adjustments for potential confounders. To conclude, a greater polyphenol intake may thus contribute
to reducing body weight in elderly people at high cardiovascular risk.
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1. Introduction
Overweight and obesity have been steadily increasing in recent years and currently represent a
serious threat to public health [1]. In 2014, more than 1.9 billion adults were overweight worldwide,
and of these over 600 million were obese [2]. With nearly three million adults dying each year as a
result of being overweight or obese, the impact of obesity on morbidity, mortality, and health care costs
is very high [3]. Lifestyle and dietary habits are key determinants in the prevalence of obesity [4–6].
Polyphenols, the most abundant antioxidants in nature, are widely distributed in plant-derived
foods such as vegetables, fruits, seeds, coffee, wine, and tea [7]. Only a few human studies have
reported a relationship between polyphenol intake and body weight, even though obesity is considered
a major independent risk factor for various chronic diseases [8,9]. Evidence for the effects of
polyphenols on obesity parameters in humans is inconsistent, possibly due to divergence among study
designs, characteristics of the participants, and metabolic pathways. Although some intervention
clinical trials with polyphenol-enriched food or polyphenol extracts do not show any effect on weight
or waist circumference [10–12], other studies have reported that polyphenols reduce body weight
and increase energy expenditure [13–16]. The oral bioavailability of polyphenols is particularly
important because, after being modified and metabolized by enzymes, their concentration in tissues
and biological fluids is quite low [9,12,15,17]. There is therefore a need for a biomarker to accurately
reflect polyphenol concentration after their absorption and metabolism.
Polyphenol plasma levels or total urinary polyphenol excretion, considered in recent years as a
reliable biomarker of total polyphenol intake, has been correlated with dietary polyphenol intake, and
has been applied to explore associations between polyphenol intake and several chronic disease risk
parameters [18–21]. Thus, the objective of the current study was to assess the associations between
total polyphenol intake, measured by total urinary polyphenol excretion (TPE), and obesity parameters
in an elderly population at high cardiovascular risk after five years of follow up.
2. Materials and Methods
The protocol for this trial and supporting Strengthening the Reporting of Observational studies in
Epidemiology (STROBE) checklist are available as supporting information.
2.1. Ethics Statement
All participants provided informed consent. The Institutional Review Board (IRB) of the Hospital
Clinic (Barcelona, Spain), accredited by the US Department of Health and Human Services (DHHS)
update for Federal wide Assurance for the Protection of Human Subjects for International (Non-US)
Institutions #00000738, approved the study protocol on 16 July 2002. The authors confirm that
all ongoing and related trials for this drug/intervention are carried out following the rules of the
Declaration of Helsinki of 1975 and registered (ISRCTN35739639).
2.2. Subjects
Participants were drawn from the PREDIMED Study (‘Prevención con Dieta Mediterránea’
(Prevention with the Mediterranean Diet), ISRCTN35739639). The information in the registry was
delayed after recruitment began, to be sure about the feasibility of the study protocol; we started
the trial as a ‘pilot study’ on October 2003, and, once we were sure that the intervention protocol
worked, we decided to submit the study protocol for registration (date of application: 2 September
2005). The protocol and recruitment method are reported in detail elsewhere [22].
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The present study looks at 573 participants that were recruited in two centers, the Clinic Hospital
of Barcelona and the University of Valencia, both in Spain, and all were followed-up after more than
five years. The period of recruitment was from 2003 to 2006, and the average follow up was 5.9 years.
2.3. Nutritional Measurements
The selected participants were asked to complete some questionnaires: a validated 137-item food
frequency questionnaire (FFQ) to assess dietary habits [23]; a 47-item general questionnaire aimed to
summarize information about lifestyle, health condition, education, history of illnesses, and medication
use; a 14 point questionnaire evaluating the degree of adherence to the Mediterranean diet [24];
and a validated Spanish version of the Minnesota Leisure-Time Physical Activity Questionnaire to
record physical activity [25]. Nutrient intake was adjusted by calories using the residual method [26].
All questionnaires were administered and repeated yearly during the follow up by trained staff in
face-to-face interviews.
2.4. Urine Samples
Spot urine samples from the participants were collected and coded at the clinic by a technician
and then immediately shipped to a central laboratory to be stored at −80 ◦C until analyzed.
2.5. TPE Measurements
The Folin-Ciocalteu method was applied to determine the content of TPE, using a clean-up
procedure with solid phase extraction (SPE) performed in 96-well plate cartridges (Oasis MAX),
which helped to remove urinary interferences. Finally, TPE was expressed as milligrams of
gallic acid equivalent (GAE)/g of creatinine. All details have been previously described by
Medina-Remón et al. [19].
2.6. Measurements
Weight and height were measured with calibrated scales and a wall-mounted stadiometer,
respectively. Body mass index (BMI) was calculated as weight in kilograms divided by the square
of height in meters. Waist circumference (WC) was measured midway between the lowest rib and
the iliac crest. Waist-to-height ratio (WHtR) was calculated as the waist in centimeters divided by
the height in meters. Blood pressure was determined in triplicate using a validated semi-automatic
sphygmomanometer (Omron HEM-705CP, Tokyo, Japan) by trained nurses. Measurements were taken
at three time points, separated by 2 min, while the participant was in a seated position after 5 min of
rest [27]. Obesity is defined as BMI more than 30 kg/m2.
2.7. Statistical Analysis
Results were expressed as mean ± SD for continuous variables or percentages for categorical
variables. Kolmogorov and Levene tests were applied to examine the normality distribution and
skewness. All participants, including total subjects, males, and females were divided into five
categories according to their TPE at the fifth year of follow up. Changes in nutrient intakes and
key food consumption according to the FFQs were assessed with yearly repeated-measures analysis
during the follow up period. A Bonferroni post-hoc test and paired t-test were used to compare each
variable within and between groups.
Multiple linear regression models were used to assess the relationship between anthropometric
parameters (Body weight (BW), BMI, WC, and WHtR) and quintiles of TPE at the fifth year, adjusted
for potential confounders, including sex, age, intervention groups, smoking status (never, current,
former), family history of coronary heart disease (CHD), physical activity, hypertension, diabetes,
dyslipidemia, marital status (single, married, widowed), education level (primary school, high school,
university), medication used (antihypertensive drugs, vitamins, insulin, oral hypoglycemic drugs,
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aspirin, or other antiplatelet drug supplements taken in the last month), recruitment centers, 14 unit
Mediterranean diet score, and energy intake at baseline. Multiple logistic regression analyses were
used to calculate the odds ratio (OR) for quintiles of TPE and obesity (BMI > 30 kg/m2). Models were
adjusted for potential confounders as in linear regression analyses.
All analyses were performed using SPSS software V21.0 (SPSS Inc., Chicago, IL, USA,). All models
were tested for the detection of outliers, multicollinearity, homoscedasticity, and normality and
independence of errors. All statistical tests were two-tailed, and the significance level was p < 0.05.
The detailed information of the participants is available as supporting information.
3. Results
A total of 650 subjects were randomly selected from two centers, the Hospital Clinic of Barcelona
and the University of Valencia. From them, 38 were excluded because they did not meet the inclusion
criteria during the intervention, and, after five years, 39 were excluded because their TPE concentrations
were considered outliers, which was defined as any data point more than 1.5 interquartile ranges below
the first quartile or above the third quartile; hence a total of 573 participants were finally included
(Figure 1).
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The baseline characteristics of participants grouped by quintiles of TPE at baseline are shown
in Table 1. There were a total of 277 men and 296 women with a mean age of 66.2 ± 6.1 years and
68.3 ± 5.4 years, respectively. Of those participants, 41.5% had diabetes, 80.5% had hypertension, 66.8%
had dyslipidemia, 16.9% were current smokers, and 37.5% had a family history of CHD. Compared
with participants with the lowest TPE, those with higher TPE were more likely to be o en, older, less
likely to s oke, and also had lower body weight. 4 sho s the lowest prevalence of hypertension.
Nutrients 2017, 9, 452 5 of 19
Table 1. Baseline characteristics of participants according to quintiles of total urinary polyphenol excretion (TPE) at baseline.
TPE (mg GAE/g Creatinine)
Q1 Q2 Q3 Q4 Q5
p
(<76.55) (76.56–95.20) (95.21–119.18) (119.19–145.86) (>145.86)
No. of subjects 114 - 115 - 115 - 115 - 114 - -
Women, n (%) 33 28 49 42.6 66 57.4 65 56.5 83 72.8 <0.001
Age (y), mean (SD) 66.4 5.9 66.6 6.0 66.9 5.9 67.7 5.7 68.9 5.8 0.007
Weight (kg), mean (SD) 80.2 11.8 77.7 10.4 73.7 9.1 73.3 10.9 70.8 10.4 <0.001
BMI (kg/m2), mean (SD) 29.8 2.9 29.5 3.2 29.1 3.1 28.9 3.6 28.8 3.4 0.080
Systolic BP (mm Hg), mean (SD) 150.9 16.9 153.9 19.5 149.9 17.0 151.8 19.5 150.4 15.9 0.454
Diastolic BP (mm Hg), mean (SD) 86.4 10.5 86.1 10.4 85.0 9.9 84.2 10.3 84.4 9.1 0.363
Hypertension, n (%) 93 81.6 102 88.7 94 81.7 79 68.7 93 81.6 0.004
Diabetes, n (%) 47 41.2 41 35.7 48 41.7 53 46.1 49 43.0 0.605
Dyslipidemia, n (%) 72 63.2 74 64.3 78 67.8 80 69.6 79 69.3 0.779
Smoking status, n (%) 0.002
Current 32 28.1 22 19.1 16 13.9 18 15.7 9 7.9 -
Former 26 22.8 25 21.7 24 20.9 31 27.0 20 17.5 -
Never 56 49.1 68 59.1 75 65.2 66 57.4 85 74.6 -
Family history of CHD, n (%) 39 34.2 42 36.5 45 39.1 41 35.7 48 42.1 0.95
Medication, n (%) -
Aspirin 21 18.4 17 14.8 27 23.5 19 16.5 19 16.7 0.482
Antihypertensive drugs 87 76.3 90 78.3 82 71.3 71 61.7 84 73.7 0.049
Hypolipidemic drugs 40 35.1 45 39.1 50 43.5 53 46.1 51 44.7 0.426
Insulin 3 2.6 7 6.1 4 3.5 7 6.1 6 5.3 0.639
Oral hypoglycemic drugs 23 20.2 22 19.1 29 25.2 30 26.1 27 23.7 0.652
Vitamin or minerals 5 4.4 5 4.3 10 8.7 9 7.8 18 15.8 0.005
Education level, n (%) 0.348
University 13 11.4 16 13.9 10 8.7 7 6.1 9 7.9 -
High school 21 18.4 14 12.2 18 15.7 22 19.1 13 11.4 -
Primary school 79 69.3 83 72.2 85 73.9 86 74.8 92 80.7 -
Marital status, n (%) 0.168
Single 7 6.1 5 4.3 4 3.5 3 2.6 6 5.3 -
Married 96 84.2 93 80.9 93 80.9 88 76.5 80 70.2 -
Widowed 10 8.8 14 12.2 16 13.9 24 20.9 25 21.9 -
Physical activity at leisure time
(MET-min/d), mean (SD) 267.5 222.5 302.7 256.3 233 172.9 283.7 271.3 261.7 247.3 0.237
TPE: total polyphenol excretion; GAE: gallic acid equivalent; BMI: body mass index; BP: blood pressure; CHD: coronary heart diseases. Data are given as means (SD) for continuous
variables and percentages for categorical variables; p < 0.05 indicates statistical significance. * p-values calculated by analysis of variance or χ2 tests.
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The comparison of total urinary polyphenol excretion between baseline and the fifth year of
follow up by quintiles of TPE at the fifth year is shown in Figure 2. For the first two quintiles, TPE at
baseline was significantly higher than at the fifth year. By contrast, TPE at the top two categories was
higher than at baseline.
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Table 2. Changes in key food intake and nutrients according to the food frequency questionnaires (FFQs) after energy adjustment categorized by quintile of TPE at the
fifth year a.
TPE (mg GAE/g Creatinine)
Q1 Q2 Q3 Q4 Q5
p b p c
(<79.02) (79.03–99.50) (99.51–124.53) (124.54–160.06) (>160.07)
Mean SD Mean SD Mean SD Mean SD Mean SD ANOVA TIME GROUP INTERACTION
Vegetables (g/day) baseline 302.6 126.5 295.2 122.6 283.3 114.1 312.9 142.4 297.0 107.0 0.484 <0.001 0.916 0.440
changes 47.7 ** 131.5 53.1 ** 130.2 76.3 ** 150.4 46.0 ** 162.3 59.0 ** 131.6 0.514
Fruits (g/day) baseline 328.9 184.8 361.6 179.7 358.6 182.3 389.5 162.5 394.5 189.3 0.064 <0.001 0.051 0.530
changes 89.1 ** 220.1 82.9 ** 222.7 111.0 ** 220.6 80.6 ** 208.4 67.9 ** 194.8 0.658
Legumes (g/day) baseline 18.5 8.4 19.3 7.4 20.0 9.2 19.2 7.2 19.0 6.6 0.634 0.446 0.251 0.045
changes 0.3 10.7 1.7 11.3 −3.2 29.1 −1.0 8.5 1.0 8.3 0.160
Cereals (g/day) baseline 246.8 83.8 246.3 81.2 232.8 74.2 242.9 71.9 237.7 61.9 0.636 <0.001 0.530 0.386
changes −22.2 * 91.1 −21.7 ** 85.1 −14.5 91.5 −31.4 ** 80.1 −25.6 ** 77.5 0.673
Milk (g/day) baseline 322.8 191.3 370.1 202.2 365.8 210.0 354.5 203.7 422.5 231.6 0.010 0.005 0.009 0.728
changes 38.3 207.4 21.4 200.9 10.3 198.6 40.2 * 188.3 20.6 208.9 0.776
Meat (g/day) baseline 138.1 50.4 136.2 43.9 145.6 56.5 139.3 41.7 141.6 47.1 0.613 <0.001 0.198 0.983
changes −9.9 52.1 −13.9 ** 44.6 −12.1 * 52.5 −13.8 ** 51.5 −11.7 * 47.7 0.975
Fish (g/day) baseline 92.0 39.6 92.5 36.9 90.4 38.0 97.0 41.3 93.0 39.0 0.787 0.005 0.970 0.481
changes 8.2 * 40.4 6.2 42.2 11.5 ** 44.2 4.2 39.4 7.3 43.3 0.764
Pastries (g/day) baseline 29.6 32.1 23.6 22.4 24.1 24.7 23.9 22.4 26.6 26.5 0.379 0.006 0.291 0.920
changes −4.8 32.4 −3.0 29.4 −4.3 27.2 −3.2 24.3 −3.9 29.2 0.991
EVOO (g/day) baseline 22.7 25.6 20.5 22.4 22.6 23.6 22.9 23.7 22.8 23.3 0.960 <0.001 0.961 0.626
changes 24.9 ** 29.6 27.6 ** 27.6 25.4 ** 28.2 26.4 ** 30.1 26.9 ** 25.6 0.955
Olive oil (g/day) baseline 45.4 17.6 46.3 14.2 45.3 13.5 46.3 14.5 44.2 15.3 0.791 <0.001 0.575 0.161
changes 7.8 ** 18.2 10.5 ** 17.5 9.8 ** 16.8 9.3 ** 18.7 11.2 ** 16.8 0.654
Nuts (g/day) baseline 10.7 14.2 11.2 12.6 10.0 12.7 10.0 13.6 10.9 11.5 0.904 <0.001 0.634 0.192
changes 3.1 16.4 5.3 ** 17.1 5.5 ** 15.8 9.5 ** 17.3 4.2 ** 14.0 0.039
Wine (g/day) baseline 104.9 144.8 97.0 138.3 103.9 171.5 98.2 136.2 81.2 125.6 0.739 0.013 0.647 0.984
changes −8.4 124.2 −13.3 129.4 −17.1 111.3 −18.1 * 95.3 −14.5 91.9 0.971
Tea (mL) baseline 4.8 14.5 4.6 15.1 6.4 17.0 5.2 12.5 7.6 21.1 0.605 0.401 0.479 0.172
changes 0.1 16.6 −1.9 14.5 −1.8 16.7 3.2 24.9 −2.0 22.4 0.204
Coffee (mL) baseline 39.1 58.4 36.7 52.4 30.7 43.0 35.0 47.1 30.9 43.0 0.717 0.002 0.546 0.098
changes −11.5 * 50.1 −1.8 50.2 −7.3 * 36.8 −13.1 ** 47.0 3.7 51.3 0.048
Total carbohydrates (g/day) baseline 237.5 43.2 242.1 38.0 237.0 41.7 235.8 36.3 239.7 34.8 0.682 0.769 0.114 0.025
changes 4.5 78.6 −10.3 71.6 5.7 72.4 −13.2 * 68.1 −0.4 64.6 0.166
Protein (g/day) baseline 90.3 43.2 94.9 38.0 89.7 41.7 88.5 36.3 92.5 34.8 0.682 0.274 0.307 0.474
changes 2.3 47.6 −3.0 41.4 6.1 46.9 2.5 40.9 4.6 39.6 0.592
Nutrients 2017, 9, 452 8 of 19
Table 2. Cont.
TPE (mg GAE/g Creatinine)
Q1 Q2 Q3 Q4 Q5
p b p c
(<79.02) (79.03–99.50) (99.51–124.53) (124.54–160.06) (>160.07)
Mean SD Mean SD Mean SD Mean SD Mean SD ANOVA TIME GROUP INTERACTION
Total Fat (g/day) baseline 100.4 13.6 100.9 12.7 102.8 13.7 102.7 12.9 104.5 13.6 0.132 <0.001 0.235 0.981
changes 10.0 ** 30.8 9.2 ** 28.5 10.9 ** 28.0 8.5 ** 26.9 9.4 ** 31.5 0.980
Fiber (g/day) baseline 24.2 6.0 24.5 6.5 24.2 6.5 25.8 5.8 25.5 5.6 0.256 0.006 0.632 0.013
changes 1.1 8.2 1.4 9.7 3.2 ** 8.4 0.2 8.2 1.0 7.8 0.107
Alcohol (g/day) baseline 13.5 5.6 13.6 5.2 13.7 5.3 13.3 4.7 14.2 4.9 0.780 0.032 0.961 0.765
changes −0.2 17.8 −1.6 15.0 −1.2 16.7 −1.9 14.4 −3.2 * 14.2 0.707
SFA (g/day) baseline 24.9 11.2 24.2 9.7 24.5 8.3 25.7 9.1 23.9 9.9 0.663 0.541 0.772 0.266
changes −0.5 12.9 −0.1 10.6 0.7 9.8 −1.5 11.1 1.6 11.3 0.301
MUFA (g/day) baseline 52.1 16.8 51.3 15.4 52.4 16.0 53.6 14.5 52.4 15.0 0.828 <0.001 0.941 0.694
changes 6.0 ** 20.3 7.5 ** 19.2 7.4 ** 17.5 4.8 ** 18.1 7.1 ** 19.0 0.798
PUFA (g/day) baseline 15.6 5.2 15.4 5.7 15.5 5.8 16.0 5.2 15.5 5.5 0.887 <0.001 0.575 0.670
changes 3.0 ** 7.7 3.1 ** 7.8 3.4 ** 7.1 3.4 ** 8.1 4.2 ** 8.9 0.800
Folic acid (µg/day) baseline 379.3 89.5 373.3 90.5 369.8 76.5 394.4 98.8 394.2 85.7 0.152 <0.001 0.447 0.086
changes 42.7 ** 91.3 46.5 ** 99.7 65.7 ** 92.6 39.2 ** 91.6 38.7 ** 100.4 0.196
Cholesterol (mg/day) baseline 354.9 92.4 340.0 92.2 351.4 93.3 353.5 81.6 359.1 95.5 0.505 0.234 0.406 0.329
changes 0.2 115.0 11.9 101.3 11.4 109.2 −3.5 105.5 15.2 112.6 0.644
Na (mg/day) baseline 2331.2 570.5 2254.1 499.7 2272.1 480.3 2286.1 491.3 2298.5 447.1 0.815 0.257 0.258 0.319
changes −64.0 941.6 −83.1 728.6 10.6 730.0 −184.2 ** 713.4 10.8 752.6 0.306
K (mg/day) baseline 4130.5 769.6 4218.7 756.2 4208.9 696.0 4312.6 808.1 4410.2 748.0 0.069 <0.001 0.246 0.067
changes 379.8 ** 1070.7 286.0 ** 1042.2 497.3 ** 1007.2 249.1 * 1116.2 268.1 * 1100.4 0.389
Mg (mg/day) baseline 355.0 64.0 361.1 68.6 356. 56.6 368.6 58.2 374.8 61.9 0.147 <0.001 0.474 0.056
changes 30.7 ** 97.9 26.8 ** 99.2 42.9 ** 87.9 22.0 ** 87.3 23.9 * 95.9 0.481
P-14 score baseline 8.9 1.8 9.0 1.8 9.2 1.9 8.8 1.9 9.1 1.8 0.441 <0.001 0.370 0.571
changes 1.6 ** 2.5 1.8 ** 1.9 1.7 ** 2.1 1.9 ** 2.0 1.6 ** 2.1 0.626
Energy intake (Kcal/day) baseline 2508.8 582.3 2285.5 578.5 2338.5 463.0 2262.2 510.7 2191.7 470.7 <0.001 0.034 <0.001 0.234
changes −25.9 627.6 32.0 497.4 100.2 * 503.9 8.9 564.0 157.8 ** 520.1 0.089
TPE: total polyphenol excretion; GAE: gallic acid equivalent; EVOO: Extra Virgin Olive Oil; SFA: saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated
fatty acids; Na: sodium; K: potassium; Mg: magnesium; p-14: 14 item dietary score test to appraise adherence of participants to the Mediterranean diet (it includes questions about
consumption of fruits, vegetables, meat, fish, carbonic beverages, legumes, nuts, olive oil, wine, and culinary methods) [28]. a Data are given as means (SD); p < 0.05 indicates statistical
significance. Values with asterisks are statistically different from baseline by paired-samples t-test (* p < 0.05; ** p < 0.01). b Data were analyzed by one-way ANOVA. c Data analyzed by
repeated-measures two-factor ANOVA.
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The associations between TPE and obesity indexes were analyzed by linear regression models
(Table 3). For total participants, significant inverse associations were found between quintiles of TPE at
the fifth year and BW (β = −1.004; p = 0.002), BMI (β = −0.320; p = 0.005), WC (β = −0.742; p = 0.013),
and WHtR (β = −0.408; p = 0.036) after adjustment for potential confounders. For males, inverse
associations were found in BW (β = −0.959; p = 0.039) and BMI (β = −0.301; p = 0.034), while, for
females, only an inverse association was found in BMI (β = −0.332; p = 0.046) after a full adjustment.
Table 3. Multiple linear regression analyses with obesity indexes and quintiles of TPE at the fifth year
for male, female, and total participants.
β SE Beta Significance 95% CI
BW (kg) Male Model 1 −1.446 0.440 −0.195 0.001 −2.313 −0.580
Model 2 −1.259 0.440 −0.170 0.005 −2.126 −0.392
Model 3 −0.959 0.461 −0.131 0.039 −1.868 −0.050
Female Model 1 −1.103 0.415 −0.153 0.008 −1.920 −0.287
Model 2 −0.756 0.414 −0.105 0.069 −1.571 0.058
Model 3 −0.757 0.431 −0.107 0.080 −1.606 0.091
Total Model 1 −2.350 0.331 −0.285 <0.001 −3.000 −1.700
Model 2 −1.070 0.315 −0.130 0.001 −1.689 −0.451
Model 3 −1.004 0.320 −0.124 0.002 −1.634 −0.375
BMI (kg/m2) Male Model 1 −0.405 0.135 −0.179 0.003 −0.670 −0.139
Model 2 −0.370 0.136 −0.164 0.007 −0.639 −0.102
Model 3 −0.301 0.141 −0.135 0.034 −0.579 −0.023
Female Model 1 −0.344 0.156 −0.127 0.028 −0.652 −0.037
Model 2 −0.296 0.160 −0.110 0.064 −0.611 0.018
Model 3 −0.332 0.165 −0.123 0.046 −0.657 −0.007
Total Model 1 −0.295 0.104 −0.118 0.005 −0.499 −0.090
Model 2 −0.328 0.110 −0.131 0.003 −0.544 −0.111
Model 3 −0.320 0.113 −0.129 0.005 −0.541 −0.098
WC (cm) Male Model 1 −0.769 0.364 −0.127 0.036 −1.487 −0.052
Model 2 −0.786 0.369 −0.130 0.034 −1.513 −0.059
Model 3 −0.516 0.378 −0.087 0.173 −1.260 0.228
Female Model 1 −0.546 0.409 −0.078 0.183 −1.351 0.259
Model 2 −0.527 0.419 −0.075 0.209 −1.351 0.297
Model 3 −0.701 0.434 −0.101 0.108 −1.556 0.154
Total Model 1 −1.500 0.296 −0.208 <0.001 −2.082 −0.918
Model 2 −0.721 0.293 −0.100 0.014 −1.296 −0.147
Model 3 −0.742 0.297 −0.104 0.013 −1.326 −0.158
WHtR (cm/m) Male Model 1 −0.340 0.220 −0.093 0.124 −0.773 0.094
Model 2 −0.385 0.223 −0.105 0.085 −0.823 0.054
Model 3 −0.258 0.229 −0.072 0.261 −0.710 0.193
Female Model 1 −0.246 0.276 −0.052 0.374 −0.789 0.298
Model 2 −0.332 0.282 −0.070 0.240 −0.887 0.223
Model3 −0.501 0.294 −0.106 0.089 −1.079 0.078
Total Model 1 −0.298 0.178 −0.070 0.094 −0.648 0.051
Model 2 −0.367 0.189 −0.087 0.052 −0.739 0.004
Model 3 −0.408 0.194 −0.097 0.036 −0.788 −0.028
BW: body weight; BMI: body mass index; WC: waist circumference; WHtR: waist-to-height ratio. TPE: total
polyphenol excretion (mg GAE/g creatinine). β: Non-standardized coefficient (regression line coefficient); SE:
Standard error; Beta: Standardized coefficient; CI: Confidence interval; p: two-sided test of significance. Model 1,
unadjusted; Model 2 was adjusted for sex (only for total participants), age, and intervention groups; Model 3 adjusted
as in Model 2 plus smoking status (never, current, former), family history of CHD, physical activity, hypertension,
diabetes, dyslipidemia, marital status (single, married, divorced, widowed), education level (primary school, high
school, university), medication used (antihypertensive drugs, vitamins, insulin, oral hypoglycemic drugs, aspirin,
or other antiplatelet drug supplements taken in the last month), recruitment centers, 14 unit Mediterranean diet
score, and energy intake at baseline.
Table 4 shows the odds ratio (OR) and a 95% CI for obesity according to the quintile of TPE at
the fifth year. In fully adjusted models, for total participants in the category of highest TPE had a
lower prevalence of obesity (OR = 0.346, 95% CI = 0.176 to 0.178; p-trend = 0.039) than those in the
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lowest category. For males, compared with the reference group, the top quintile group (Q5) showed
significant reduction in the prevalence of obesity (OR = 0.340, 95% CI = 0.146 to 0.792 in Model 2).
Table 4. Multivariate adjusted odds ratios (95% confidence interval (CI)) for prevalent obesity (213 cases)
after a five years follow up.
Q1 Q2 95% CI Q3 95% CI Q4 95% CI Q5 95% CI p
Male Model 1 1 (ref.) 0.531 0.244 1.155 0.545 0.250 1.188 0.488 0.223 1.070 0.313 0.135 0.722 0.095
(90 case) Model 2 1 (ref.) 0.559 0.254 1.229 0.571 0.260 1.254 0.520 0.235 1.148 0.340 0.146 0.792 0.159
Model 3 1 (ref.) 0.586 0.243 1.416 0.588 0.238 1.452 0.511 0.204 1.283 0.387 0.146 1.029 0.418
Female Model 1 1 (ref.) 0.934 0.454 1.924 0.791 0.384 1.628 0.643 0.310 1.333 0.429 0.200 0.919 0.195
(123 case) Model 2 1 (ref.) 1.041 0.497 2.182 0.844 0.403 1.768 0.769 0.361 1.638 0.493 0.226 1.078 0.352
Model 3 1 (ref.) 1.257 0.538 2.934 0.748 0.317 1.764 0.595 0.244 1.450 0.461 0.181 1.170 0.223
Total Model 1 1 (ref.) 0.639 0.375 1.089 0.769 0.454 1.302 0.664 0.390 1.129 0.450 0.259 0.782 0.073
(213 case) Model 2 1 (ref.) 0.597 0.344 1.035 0.691 0.400 1.192 0.618 0.350 1.091 0.383 0.211 0.694 0.036
Model 3 1 (ref.) 0.604 0.332 1.100 0.720 0.399 1.300 0.560 0.298 1.054 0.346 0.176 0.678 0.039
Quintiles for males: Q1 < 70.61; Q2: 70.62–88.94; Q3: 88.95–108.61; Q4: 108.62–137.11; Q5 > 137.11; Quintiles
for females: Q1 < 91.67; Q2: 91.68–113.96; Q3: 113.97–138.28; Q4: 138.29–181.01; Q5 > 181.01; Quintiles for total:
Q1 < 79.02; Q2: 79.03–99.50; Q3: 99.51–124.53; Q4: 124.54–160.06; Q5 > 160.06. TPE is expressed as mg GAE/g
creatinine. Obesity was defined as BMI > 30 kg/m2. Model 1, unadjusted; Model 2 was adjusted for sex (only
for total participants), age, and intervention groups; Model 3 adjusted as in Model 2 plus smoking status (never,
current, former), family history of CHD, physical activity, hypertension, diabetes, dyslipidemia, marital status
(single, married, divorced, widowed), education level (primary school, high school, university), medication used
(antihypertensive drugs, vitamins, insulin, oral hypoglycemic drugs, aspirin or other antiplatelet drug supplements
taken in the last month) recruitment centers, 14 unit Mediterranean diet score, and energy intake at baseline.
Table 5 shows the incidence of obesity after five years of intervention, conducted in subjects
without obesity at baseline and adjusted for TPE and BW at baseline and other co-variables. The results
show significant reduction in the incidence of obesity (odds ratio (OR) = 0.095, 95% confidence interval
(CI) 0.018 to 0.498; p-trend, 0.018) at the end of the follow up after adjustments.
Table 5. Association between TPE after five years of follow up and the incidence of obesity
(39 new-onset case).
Q1 Q2 95% CI Q3 95% CI Q4 95% CI Q5 95% CI p
Model 1 1 (ref.) 0.912 (0.337 2.468) 0.676 (0.253 1.810) 0.351 (0.142 0.866) 0.406 (0.164 1.005) 0.054
Model 2 1 (ref.) 0.454 (0.185 1.115) 0.235 (0.072 0.767) 0.285 (0.093 0.868) 0.145 (0.037 0.558) 0.014
Model 3 1 (ref.) 0.382 (0.146 1.001) 0.193 (0.055 0.676) 0.272 (0.084 0.885) 0.119 (0.028 0.505) 0.014
Model 4 1 (ref.) 0.366 (0.126 1.062) 0.156 (0.040 0.612) 0.218 (0.054 0.881) 0.095 (0.018 0.498) 0.018
Model 1, unadjusted; Model 2 was adjusted for baseline TPE and baseline BW; Model 3 was adjusted as in
Model 2 plus sex, age, and intervention groups; Model 4 was adjusted as in Model 3 plus smoking status (never,
current, former), family history of CHD, physical activity, hypertension, diabetes, dyslipidemia, marital status
(single, married, divorced, widowed), education level (primary school, high school, university), medication used
(antihypertensive drugs, vitamins, insulin, oral hypoglycemic drugs, aspirin, or other antiplatelet drug supplements
taken in the last month) recruitment centers, 14 unit Mediterranean diet score, and energy intake at baseline.
Table 6 shows the associations between TPE at the fifth year and changes in anthropometric
parameters, analyzed by linear regression models. For total participants, inverse associations were
found between changes in BW (β = −0.363; p = 0.024) and BMI (β = −0.145; p = 0.023) and TPE in the
fifth year after adjustment. For males, there was not any inverse association, while for females, inverse
associations were found for changes in BW (β = −0.568; p = 0.008) and BMI (β = −0.221; p = 0.017)
after adjustment.
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Table 6. Multiple linear regression analyses with changes in anthropometric parameters and quintiles
of TPE at the fifth year.
β SE Beta p 95% CI
Changes in BW Male Model 1 −0.098 0.211 −0.028 0.642 −0.514 0.318
(kg) Model 2 −0.229 0.217 −0.066 0.294 −0.657 0.199
Model 3 −0.186 0.217 −0.053 0.393 −0.614 0.242
Model 4 −0.037 0.233 −0.011 0.872 −0.495 0.421
Female Model 1 −0.648 0.193 −0.193 0.001 −1.027 −0.269
Model 2 −0.664 0.196 −0.197 0.001 −1.049 −0.279
Model 3 −0.573 0.197 −0.17 0.004 −0.961 −0.185
Model 4 −0.568 0.213 −0.169 0.008 −0.987 −0.149
Total Model 1 −0.429 0.142 −0.125 0.003 −0.709 −0.149
Model 2 −0.539 0.15 −0.157 <0.001 −0.835 −0.244
Model 3 −0.436 0.153 −0.127 0.005 −0.737 −0.135
Model 4 −0.363 0.161 −0.108 0.024 −0.68 −0.047
Changes in BMI Male Model 1 −0.04 0.075 −0.033 0.589 −0.187 0.107
(kg/m2) Model 2 −0.087 0.077 −0.07 0.259 −0.238 0.064
Model 3 −0.072 0.077 −0.059 0.348 −0.224 0.079
Model 4 −0.019 0.082 −0.016 0.817 −0.18 0.142
Female Model 1 −0.256 0.083 −0.177 0.002 −0.419 −0.092
Model 2 −0.262 0.084 −0.181 0.002 −0.428 −0.096
Model 3 −0.223 0.085 −0.154 0.009 −0.391 −0.056
Model 4 −0.221 0.092 −0.153 0.017 −0.402 −0.04
Total Model 1 −0.176 0.056 −0.13 0.002 −0.286 −0.065
Model 2 −0.215 0.059 −0.159 <0.001 −0.331 −0.098
Model 3 −0.172 0.06 −0.128 0.005 −0.291 −0.054
Model 4 −0.145 0.064 −0.109 0.023 −0.27 −0.02
Changes in WC Male Model 1 −0.066 0.233 −0.017 0.776 −0.525 0.392
(cm) Model 2 −0.209 0.241 −0.054 0.386 −0.684 0.265
Model 3 −0.17 0.242 −0.044 0.484 −0.647 0.307
Model 4 −0.108 0.249 −0.029 0.666 −0.599 0.383
Female Model 1 −0.34 0.275 −0.072 0.217 −0.88 0.2
Model 2 −0.325 0.28 −0.069 0.247 −0.877 0.227
Model 3 −0.31 0.286 −0.066 0.279 −0.872 0.253
Model 4 −0.42 0.311 −0.089 0.178 −1.033 0.192
Total Model 1 −0.237 0.181 −0.055 0.190 −0.592 0.118
Model 2 −0.302 0.192 −0.070 0.118 −0.680 0.076
Model 3 −0.252 0.198 −0.059 0.203 −0.640 0.136
Model 4 −0.269 0.207 −0.063 0.195 −0.676 0.138
Changes in WHtR Male Model 1 −0.066 0.233 −0.017 0.776 −0.525 0.392
(cm/m) Model 2 −0.209 0.241 −0.054 0.386 −0.684 0.265
Model 3 −0.17 0.242 −0.044 0.484 −0.647 0.307
Model 4 −0.108 0.249 −0.029 0.666 −0.599 0.383
Female Model 1 −0.202 0.179 −0.066 0.262 −0.555 0.152
Model 2 −0.194 0.183 −0.063 0.29 −0.555 0.166
Model 3 −0.184 0.187 −0.06 0.325 −0.552 0.183
Model 4 −0.262 0.204 −0.085 0.199 −0.663 0.139
Total Model 1 −0.142 0.114 −0.052 0.216 −0.367 0.083
Model 2 −0.184 0.122 −0.068 0.131 −0.424 0.055
Model 3 −0.155 0.125 −0.057 0.215 −0.401 0.091
Model 4 −0.167 0.131 −0.062 0.203 −0.426 0.091
TPE: total polyphenol excretion; GAE: gallic acid equivalent; BW: body weight; BMI: body mass index. WC: waist
circumference; WHtR: waist-to-height ratio. Model 1, unadjusted; Model 2 was adjusted for baseline TPE and
baseline BW; Model 3 was adjusted as in Model 2 plus sex (only for total participants), age, and intervention groups;
Model 4 was adjusted as in Model 3 plus smoking status (never, current, former), family history of CHD, physical
activity, hypertension, diabetes, dyslipidemia, marital status (single, married, divorced, widowed), education
level (primary school, high school, university), medication used (antihypertensive drugs, vitamins, insulin, oral
hypoglycemic drugs, aspirin, or other antiplatelet drug supplements taken in the last month) recruitment centers,
14 unit Mediterranean diet score, and energy intake at baseline.
Changes in obesity parameters for male, female, and total participants between baseline and end
of follow up were observed (Table S1). For total participants, subjects in the highest TPE category
had the lowest BW (70.29 ± 10.25 kg) and BMI (28.40 ± 3.75 kg/m2) after the intervention. Inversely,
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those participants in the first quintile of TPE had significantly higher WC (101.41 ± 9.35 cm) and
WHtR (61.80 ± 5.15) compared with baseline values. For males, there was a significant inverse trend
among quintiles and BW and BMI both at baseline and the fifth year. Also a significant reduction
was observed comparing the top quintile with the bottom quintile both at baseline and the fifth year.
For females, there was a significant reduction of BW and BMI in the top quintile groups after five years
of intervention.
Table S2 shows the associations between changes in anthropometric parameters and changes in
TPE over five years with linear regression models. For total participants, inverse associations were
found between changes in BW (β = −0.355; p = 0.036), BMI (β = −0.139; p = 0.037) and TPE five
years after adjustment. For males, there was not any inverse association, while, for females, inverse
associations were found for changes in BW (β = −0.723; p = 0.003), BMI (β = −0.283; p = 0.006), and
WC (β = −0.701; p = 0.046) after adjustment.
4. Discussion
In this five years study conducted in elderly participants at high cardiovascular risk, a higher
total polyphenol intake, expressed as TPE, was inversely associated with weight parameters including
BW, BMI, WC, and WHtR, as well as with the prevalence of obesity after a five years follow up,
suggesting that polyphenols could be considered an independent contributor to the weight loss effects
of a Mediterranean diet.
Several PREDIMED sub-trials have reported a range of mechanisms for the weight loss effects of
a Mediterranean diet, including a high ingestion of dietary fiber, antioxidants, unsaturated fatty acids,
extra virgin olive oil, nuts, and moderate wine consumption [29–35]. The reduction we observed in
weight parameters might be partly attributed to the intake of the aforementioned food items; however,
in the fully adjusted models, we removed their effects by adjusting for adherence to the Mediterranean
diet (14 unit MedDiet questionnaire). Furthermore, even though the intake of these foods increased
after five years of follow up, none of them showed significant differences within quintile categories at
the end of the intervention; therefore, polyphenol intake could be considered an independent factor.
The present findings are consistent with previous reports on the inverse associations between
polyphenol intake and weight parameters. A 16 years longitudinal study from the Netherlands
associated a higher intake of total flavonols/flavones and catechins with a lower increase in BMI [36].
Other supporting evidence showed a significant decrease of 1.9 cm in WC and 1.2 kg in BW after
supplementation of catechin-rich green tea for 90 days, although at a much higher dose than habitual
intakes [37]. Two 12 week intervention studies also demonstrated the anti-obesity effects of green
tea intake, finding a considerable reduction in BW, BMI, WC, and total abdominal fat area [38,39].
Another clinical trial indicated that consumption of normal or high-polyphenolic orange juice reduced
body weight in obese or overweight adults, demonstrating an inverse association between polyphenol
intake and body weight [10]. On the contrary, the effect of daily decaffeinated green tea intake
on weight and body composition were tested among a group population in overweight breast
cancer survivors. Results showed a slight but not significant increasing in weight loss after the
intervention [40]. Compared with Asian populations, Caucasians show inconsistent results: a study
showed no effects on body weight with long-term green tea extract supplementation [11]; another
study with relapsing-remitting multiple sclerosis patients using one of the main green tea polyphenols,
(-)epigal-locatechin-3-gallate, after three months of consumption showed greater muscle metabolism
improvement in males than females [41]; supplementation with resveratrol exerted significant effects
on energy metabolism in obese subjects, while another two findings showed ineffectiveness in nonobese
women and obese men [42–44]. The results are inconsistent probably because of the different doses of
polyphenol intakes, sex-specific effects, sample sizes, or length of duration.
The Mediterranean diet could be considered rich in polyphenol content because it is characterized
by a high consumption of fruit and vegetables, virgin olive oil, legumes, and nuts and a moderate
consumption of wine [45]. Results from a meta-analysis of 16 randomized controlled trials with a
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Mediterranean diet showed an average reduction in participant weight of 1.75 kg and a reduction in
BMI of 0.57 kg/m2, as well as a greater reduction in BW of 3.88 kg under conditions of energy restriction,
suggesting that adherence to a Mediterranean diet helps to control weight [46]. The PREDIMED,
the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain) cohort and the
Seguimiento Universidad de Navarra (SUN) cohort, also in Spain, have shown in the long-term
a significantly lower risk of overweightness/obesity associated with better Mediterranean diet
adherence [34,47,48]. We observed a 1.22 kg decrease in BW and 0.50 in BMI in the highest TPE quintile,
which partly agrees with previous studies reporting a similar reduction in body weight parameters.
Indexes of abdominal obesity, namely WC and WHtR, were significantly lower in the highest TPE
quintile. These parameters are more accurate discriminators of cardiovascular risk than BMI due to
the closer relationship between cardiovascular disease and abdominal obesity [49]. In agreement with
our findings, in a PREDIMED study, and several other studies, the Mediterranean diet was negatively
associated with WC and WHtR [50–52]. Additionally, two feeding trials with green tea polyphenol
extracts also showed beneficial effects on abdominal obesity parameters [39,53].
Our results indicate the weight loss effect of polyphenols is higher in females than males. There are
several possible reasons to explain the observed results: first, the prevalence of obesity is higher in
women than men, and weight loss tends to be lower in obese individuals [54]. In the current study, at
baseline, the prevalence of obesity was 32.9% for males and 44.9% for females, which is in line with
another elderly population in United States [55]. Second, a higher TPE increment was observed when
comparing females and males after five years, which may potentially explain the difference in weight
loss effectiveness. Third, self-characteristics concerning males and females may also contribute to
the difference. Women tend to have higher concentrations of leptin, an appetite regulation hormone
that helps to reduce energy intake [56]. Evidence shows a significant inverse association between
polyphenol intakes and plasma leptin levels, indicating higher polyphenol intake responses to better
weight loss effectiveness [10]. Furthermore, individual differences in the composition of the gut
microbiota may also contribute to differences in bioavailability and polyphenolic metabolites, further
influencing the weight loss effectiveness [57].
We also found less gain in WC in males, after five years of intervention. The observation could be
primarily explained by the greater percentage of muscle mass and mineral mass in males compared
with females. Waist circumference is affected by age, body weight, body composition, and fat
distribution [58]. Various types of polyphenol help to reduce visceral fat [9]. Additionally, since
waist circumference increases with age, it is worth noting that the average age is older in females in
our population, which could be considered another possible explanation.
Potential explanations of the observed inverse association between polyphenol intake and weight
loss likely involve several mechanisms due to the diversity of polyphenol chemical structures, complex
metabolic pathways, and oral bioavailability. Excess adipose mass and adipose tissue expansion
results from adipocyte hypertrophy and hyperplasia [59]. Common plausible mechanisms include
the suppression of fat absorption and anabolic pathways; inhibition of adipogenesis and lipogenesis;
stimulation of catabolic pathways with increment of lipolysis, apoptosis of mature adipocytes, and acid
β-oxidation; reduction of chronic inflammatory response relative to adiposity; and increment in energy
expenditure through up-regulating uncoupling protein (UCP1-3) [8,9]. However, knowledge of the
anti-obesity effects of polyphenols is limited and only a few specific compounds have been analyzed in
this context. For instance, it has been demonstrated that resveratrol, widely present in red grapes and
red wine, exerts an anti-obesity action by reducing adipogenesis and increasing apoptosis in mature
adipocytes and inhibiting fat accumulation processes and stimulating lipolytic and oxidative pathways
in vivo studies and clinical trials [43,60,61]. Contrary results have been observed with anthocyanins,
water-soluble plant pigments in blue, purple, and red fruits. On one hand, they seem to significantly
reduce body weight. This effect may be due to the suppression of lipid synthesis, the up-regulation of
adiponectin, which enhances insulin sensitivity, and the reduction in of serum triglycerides and leptin
levels [8,62]. However, two clinical trials showed non-significant reduction trends in body weight after
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supplementation with food rich in anthocyanins [63,64]. The anti-obesity effects of flavonoids, which
are a large group of polyphenols found in a wide range of Mediterranean diet foods [65,66], have been
mainly attributed to improvement in adipocyte functionality and fat oxidation [67]. Also playing a
key role in weight control is the down-regulation of a variety of pro-inflammatory adipocytokines,
particularly tumor necrosis factor alpha (TNF-α) [68]. A clinical trial indicates that the inhibition of
intestinal fat absorption may contribute to the weight loss after an ingestion of a green tea beverage
enriched with catechins [69]. In summary, even though the intake of some specific polyphenols has
been associated with body weight management, there is still not enough evidence for the effect of total
polyphenols or some classes of polyphenols, and further studies are needed to explore the mechanisms
involved as well as potential synergistic effects among them.
The association between weight loss and improvement in cardiovascular risk factors has been
widely discussed. Numerous studies indicate that polyphenol intake reduces cardiovascular risk
factors [70,71]. A previous study found a significant improvement in cardiovascular risk factors, with
a 5–10% of weight loss after one year [72]. We also found protective effects on cardiovascular risk
factors, including diastolic blood pressure, glucose concentration, and triglycerides concentration, with
the same population after five years of intervention [73]. A randomized study conducted in healthy
participants, feed with apple polyphenol, also supported that an improvement in cardiovascular risk
factor helps to regulate fat metabolism [74].
Some limitations of this study should be noted. First, given that the study was conducted among
elderly subjects at high cardiovascular risk, the results cannot be extrapolated to the general population.
Second, even though we adjusted for major potential confounders, we still cannot exclude residual
confounding from measurements. Third, even though WC and WHtR may reflect abdominal obesity
more accurately, they cannot differentiate between fat distribution in visceral adipose tissue and
subcutaneous abdominal adipose tissue; hence we cannot conclude if a reduction in abdominal obesity
parameters is beneficial to visceral or subcutaneous fat mass or both [75]. Another limitation is the
lack of specific measurements of polyphenol metabolism in vivo.
The present study also has several strengths. Its main strong point is the use of TPE, a biomarker
of polyphenol intake, which could provide more precise data than measuring total polyphenol intake
through self-reported information in FFQs or databases. Another strength is its prospective design.
Only a few studies have analyzed the association between total polyphenol intake and weight control,
and the current work is the first to associate anti-obesity effects with total polyphenol intake in
individuals at high cardiovascular risk [8,76]. In addition, the long-term duration of the intervention
provides more robust results compared with other short-term trials.
5. Conclusions
In summary, with five years of follow up, the present study shows that polyphenol levels
expressed as TPE in urine were inversely associated with BW, BMI, WC, and WHtR in an elderly
population at high cardiovascular risk. Therefore, we confirmed that a long-term polyphenol-rich diet
contributes to body weight loss, which can offer protection from several chronic diseases. For future
research, similar studies should be conducted in the general population, and specific mechanisms need
to be explored by further clinical trials.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6643/9/5/452/s1,
Table S1: Comparisons of obesity indexes, Table S2: Multiple linear regression analyses with changes in
anthropometric parameters and changes in quintiles of TPE over five years, File S1: STROBE checklist, File S2:
Protocol of the PREDIMED study, File S3: Database of participants.
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